Literature DB >> 11358445

NOGO mRNA expression in adult and fetal human and rat nervous tissue and in weight drop injury.

A Josephson1, J Widenfalk, H W Widmer, L Olson, C Spenger.   

Abstract

Nogo is a myelin-associated protein known to inhibit growth of neurites. In order to understand possible physiological roles of Nogo, we performed in situ hybridization using rat and human probes complementary to a Nogo-A-specific sequence and a sequence shared by all known Nogo transcripts recognizing nogo-A, -B, and -C. We studied the cellular distribution of nogo-mRNA in fetal and adult human and rat tissues, with a focus on the spinal cord and ganglia. Rat mRNA expression was also studied in a spinal cord weight-drop model and in animals exposed to kainic acid. In human fetal tissue, nogo-A was strongly expressed in the ventral two-thirds of the spinal cord, the dorsal root ganglia, and autonomic ganglia. Similarly, nogo-A mRNA expression was observed in the adult human spinal cord and ganglia. High levels of nogo-A message were observed in neurons, such as motor neurons and sensory ganglia neurons. The distribution of nogo message in rats resembled that seen in human tissues. Thus, nogo mRNA was expressed in neurons and oligodendrocytes, but not astrocytes or Schwann cells. In addition, expression of nogo-A mRNA was observed in human and rat developing muscle tissue. High level of nogo-mRNA were also expressed in the rat trigeminal ganglion and trigeminal pontine nucleus. In fetal rats the adrenal gland and cell clusters in the liver were positive for the nogo-ABC pan-probe, but negative for the nogo-A probe. While neurons in the adult rat brain were generally positive, very prominent nogo-A mRNA and nogo-ABC mRNA signals were obtained from neurons of the hippocampus, piriform cortex, the red nucleus, and the oculomotor nucleus. Nogo-A mRNA expression was markedly reduced in the epicenter of a lesion in the spinal cord of adult rats 6 and 24 h after a weight-drop injury, while no perifocal upregulation of nogo mRNA was seen. No obvious change of nogo expression was detected in kainic acid exposed animals. In conclusion our in situ hybridization study has demonstrated widespread expression of nogo mRNA in the fetal, developing and adult nervous system of rat and man. In addition to oligodendroglial cells, high levels of nogo-A mRNA expression were found in neurons, raising important questions about the function of neuronal nogo mRNA. No obvious regulation of nogo was detected following injury. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11358445     DOI: 10.1006/exnr.2001.7659

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  34 in total

Review 1.  Strategies for identifying genes that play a role in spinal cord regeneration.

Authors:  M Wintzer; M Mladinic; D Lazarevic; C Casseler; A Cattaneo; J Nicholls
Journal:  J Anat       Date:  2004-01       Impact factor: 2.610

2.  Dendritic spine alterations in neocortical pyramidal neurons following postnatal neuronal Nogo-A knockdown.

Authors:  A D Pradhan; A M Case; R G Farrer; S Y Tsai; J L Cheatwood; J L Martin; G L Kartje
Journal:  Dev Neurosci       Date:  2010-10-13       Impact factor: 2.984

3.  Selective temporal and regional alterations of Nogo-A and small proline-rich repeat protein 1A (SPRR1A) but not Nogo-66 receptor (NgR) occur following traumatic brain injury in the rat.

Authors:  Niklas Marklund; Carl T Fulp; Saori Shimizu; Rishi Puri; Asenia McMillan; Stephen M Strittmatter; Tracy K McIntosh
Journal:  Exp Neurol       Date:  2006-01       Impact factor: 5.330

Review 4.  Central nervous system regeneration inhibitors and their intracellular substrates.

Authors:  Michelle Nash; Horia Pribiag; Alyson E Fournier; Christian Jacobson
Journal:  Mol Neurobiol       Date:  2009-09-19       Impact factor: 5.590

5.  Neutralization of Nogo-A enhances synaptic plasticity in the rodent motor cortex and improves motor learning in vivo.

Authors:  Ajmal Zemmar; Oliver Weinmann; Yves Kellner; Xinzhu Yu; Raul Vicente; Miriam Gullo; Hansjörg Kasper; Karin Lussi; Zorica Ristic; Andreas R Luft; Mengia Rioult-Pedotti; Yi Zuo; Marta Zagrebelsky; Martin E Schwab
Journal:  J Neurosci       Date:  2014-06-25       Impact factor: 6.167

6.  Nogo/RTN4 isoforms and RTN3 expression protect SH-SY5Y cells against multiple death insults.

Authors:  Felicia Yu Hsuan Teng; Bor Luen Tang
Journal:  Mol Cell Biochem       Date:  2013-08-18       Impact factor: 3.396

7.  NogoA restricts synaptic plasticity in the adult hippocampus on a fast time scale.

Authors:  Andrea Delekate; Marta Zagrebelsky; Stella Kramer; Martin E Schwab; Martin Korte
Journal:  Proc Natl Acad Sci U S A       Date:  2011-01-24       Impact factor: 11.205

Review 8.  Therapeutics targeting Nogo-A hold promise for stroke restoration.

Authors:  Prateek Kumar; Lawrence D F Moon
Journal:  CNS Neurol Disord Drug Targets       Date:  2013-03       Impact factor: 4.388

9.  The expression patterns of Nogo-A and NgR in the neonatal rat visual nervous system.

Authors:  Yin Xiaolei; Yuan Rongdi; Ji Shuxing; Ye Jian
Journal:  Neurochem Res       Date:  2009-01-06       Impact factor: 3.996

10.  Nogo-a regulates neural precursor migration in the embryonic mouse cortex.

Authors:  Carole Mathis; Aileen Schröter; Michaela Thallmair; Martin E Schwab
Journal:  Cereb Cortex       Date:  2010-01-21       Impact factor: 5.357

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.